Profile
Full Name
Entrada Therapeutics, Inc.Ticker Symbol
TRDAExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
October 29, 2021Indexes
Not includedWebsite
http://www.entradatx.comEmployees
183Key Details
Price
$7.74(-6.41%)
Market cap
$290.98M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
$210.78M(+63.38% YoY)
Annual EPS
$1.68(+940.00% YoY)
PE ratio
4.05
Next earnings date
May 7, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Entrada Therapeutics doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Mar 31, 25 HC Wainwright & Co.
BuyFeb 25, 25 HC Wainwright & Co.
BuyFeb 4, 25 HC Wainwright & Co.
BuyDec 5, 24 Roth MKM
BuyNov 6, 24 Oppenheimer
OutperformNov 6, 24 HC Wainwright & Co.
BuyAug 26, 24 Oppenheimer
OutperformAug 14, 24 HC Wainwright & Co.
BuyJun 25, 24 HC Wainwright & Co.
BuyMar 18, 24 HC Wainwright & Co.
BuyInstitutional Ownership
- What is the ticker symbol for Entrada Therapeutics?
- Does Entrada Therapeutics pay dividends?
- What sector is Entrada Therapeutics in?
- What industry is Entrada Therapeutics in?
- What country is Entrada Therapeutics based in?
- When did Entrada Therapeutics go public?
- Is Entrada Therapeutics in the S&P 500?
- Is Entrada Therapeutics in the NASDAQ 100?
- Is Entrada Therapeutics in the Dow Jones?
- When was Entrada Therapeutics's last earnings report?
- When does Entrada Therapeutics report earnings?
- Should I buy Entrada Therapeutics stock now?
What is the ticker symbol for Entrada Therapeutics?
The ticker symbol for Entrada Therapeutics is NASDAQ:TRDA
Does Entrada Therapeutics pay dividends?
No, Entrada Therapeutics does not pay dividends
What sector is Entrada Therapeutics in?
Entrada Therapeutics is in the Healthcare sector
What industry is Entrada Therapeutics in?
Entrada Therapeutics is in the Biotechnology industry
What country is Entrada Therapeutics based in?
Entrada Therapeutics is headquartered in United States
When did Entrada Therapeutics go public?
Entrada Therapeutics's initial public offering (IPO) was on October 29, 2021
Is Entrada Therapeutics in the S&P 500?
No, Entrada Therapeutics is not included in the S&P 500 index
Is Entrada Therapeutics in the NASDAQ 100?
No, Entrada Therapeutics is not included in the NASDAQ 100 index
Is Entrada Therapeutics in the Dow Jones?
No, Entrada Therapeutics is not included in the Dow Jones index
When was Entrada Therapeutics's last earnings report?
Entrada Therapeutics's most recent earnings report was on Feb 27, 2025
When does Entrada Therapeutics report earnings?
The next expected earnings date for Entrada Therapeutics is May 7, 2025
Should I buy Entrada Therapeutics stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions